DE2641164A1 - 2-(4h-1,2,4-triazolyl)-benzophenone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel - Google Patents

2-(4h-1,2,4-triazolyl)-benzophenone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Info

Publication number
DE2641164A1
DE2641164A1 DE19762641164 DE2641164A DE2641164A1 DE 2641164 A1 DE2641164 A1 DE 2641164A1 DE 19762641164 DE19762641164 DE 19762641164 DE 2641164 A DE2641164 A DE 2641164A DE 2641164 A1 DE2641164 A1 DE 2641164A1
Authority
DE
Germany
Prior art keywords
carbon atoms
radical
group
general formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762641164
Other languages
German (de)
English (en)
Inventor
Toshio Fujishita
Kentaro Hirai
Teruyuki Ishiba
Hirohiko Sugimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of DE2641164A1 publication Critical patent/DE2641164A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/92—Oxygen atoms with hetero atoms directly attached to nitrogen atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19762641164 1975-12-30 1976-09-13 2-(4h-1,2,4-triazolyl)-benzophenone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel Withdrawn DE2641164A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB53224/75A GB1531980A (en) 1975-12-30 1975-12-30 Triazolylbenzophenone derivatives and preparation thereof

Publications (1)

Publication Number Publication Date
DE2641164A1 true DE2641164A1 (de) 1977-07-14

Family

ID=10467048

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762641164 Withdrawn DE2641164A1 (de) 1975-12-30 1976-09-13 2-(4h-1,2,4-triazolyl)-benzophenone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Country Status (19)

Country Link
JP (1) JPS5283469A (hu)
AR (2) AR218613A1 (hu)
AT (1) AT350052B (hu)
AU (1) AU498113B2 (hu)
BE (1) BE846410A (hu)
CA (1) CA1126274A (hu)
CH (1) CH623315A5 (hu)
DE (1) DE2641164A1 (hu)
DK (1) DK393576A (hu)
ES (3) ES451896A1 (hu)
FR (1) FR2336930A1 (hu)
GB (1) GB1531980A (hu)
HU (1) HU172539B (hu)
IE (1) IE43841B1 (hu)
IL (1) IL50664A (hu)
NL (1) NL7610799A (hu)
NZ (1) NZ181958A (hu)
SE (1) SE7609813L (hu)
ZA (1) ZA765851B (hu)

Also Published As

Publication number Publication date
JPS5283469A (en) 1977-07-12
NZ181958A (en) 1979-03-28
ES451896A1 (es) 1978-01-16
AT350052B (de) 1979-05-10
HU172539B (hu) 1978-09-28
IL50664A0 (en) 1976-12-31
NL7610799A (nl) 1977-07-04
IL50664A (en) 1983-09-30
ES462244A1 (es) 1978-06-01
AU1749876A (en) 1978-03-16
AR220519A1 (es) 1980-11-14
AR218613A1 (es) 1980-06-30
ZA765851B (en) 1977-09-28
FR2336930B1 (hu) 1978-12-22
SE7609813L (sv) 1977-07-01
ATA684276A (de) 1978-10-15
GB1531980A (en) 1978-11-15
CA1126274A (en) 1982-06-22
IE43841L (en) 1977-06-30
AU498113B2 (en) 1979-02-08
IE43841B1 (en) 1981-06-03
CH623315A5 (en) 1981-05-29
BE846410A (fr) 1977-01-17
FR2336930A1 (fr) 1977-07-29
ES462243A1 (es) 1978-06-01
DK393576A (da) 1977-07-01

Similar Documents

Publication Publication Date Title
DE2366379C2 (de) N↑α↑-geschützte N↑G↑-Nitro-L-arginyl-L-prolin-amide
EP0445796A2 (de) Essigsäurederivate
DD216717A5 (de) Verfahren zur herstellung von benzazocinon- und benzazoninon-derivaten
DE2646676A1 (de) Pyrimidonderivate, verfahren zu ihrer herstellung und daraus hergestellte arzneimittel
DE3024256A1 (de) Peptidamide, verfahren zur herstellung derselben und diese enthaltende arzneimittel
DE60132891T2 (de) Zyklische harnstoffverbindungen und verfahren zu deren herstellung
DE69837045T2 (de) Dreiringige verbindungen, verfahren zu ihrer herstellung und zwischenprodukte dieses verfahrens, ihre anwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen
DE2749988A1 (de) N-substituierte imidazolcarboxamide, verfahren zu deren herstellung und dieselben enthaltendes mittel
DD282457A5 (de) Verfahren zur herstellung neuer heterocyclischer derivate
CH638216A5 (de) Oxadiazolopyrimidin-deriate.
DE2641164A1 (de) 2-(4h-1,2,4-triazolyl)-benzophenone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3027106A1 (de) 1-(4-aminobenzyl)-2,3-dioxopiperazin- derivate, saeureadditionssalze derselben und verfahren zur herstellung derselben
DD283823A5 (de) Verfahren zur herstellung heterotetracyclischer lactamderivate
DE3021107A1 (de) Carbamoyloxyamino-1,4-benzodiazepine, verfahren zu irer herstellung und diese enthaltende arzneimittel
EP0072029B1 (de) Triazolobenzazepine, Verfahren und Zwischenprodukte zu deren Herstellung und diese enthaltende Arzneimittel
EP0054839A2 (de) 2-Acylaminomethyl-1,4-benzodiazepine und deren Salze sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3204074C2 (hu)
DE2406490A1 (de) 1,4-dihydro-3(2h)-isochinolinonverbindungen und ihre salze sowie ihre verwendung und verfahren zur herstellung derselben
DE2114441A1 (de) Benzodiazepindenvate und Ver fahren zu ihrer Herstellung
DE2527901A1 (de) Verfahren zur herstellung von neuen benzodiazepinderivaten
DE2535171C3 (de) Benzophenon-Derivate und diese Verbindungen enthaltende Arzneimittel
DE2537069C2 (hu)
DE3200258A1 (de) Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE69730615T2 (de) Verfahren zur herstellung eines tetrahydropyridinderivates
DE69915274T2 (de) Verfahren zur herstellung von methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl -amino -2-oxopyrrolidin-1-yl]propionate

Legal Events

Date Code Title Description
8141 Disposal/no request for examination